Arch Therapeutics Inc (ARTH)

[Regis999]

Arch ties to JNJ

1) Dr. Arthur L. J. Rosenthal, Ph.D., also known as Art serves as Advisor of Arch Therapeutics, Inc. He served as a Vice President of Research and Development at Johnson & Johnson Medical, Inc., from April 1990 to January 1994, and was in charge of worldwide research, development, regulatory, and clinical affairs for the JJMI Division—Google Arthur L. J. Rosenthal Ph.D. to see his impressive background.

2) retired former COO of Arch William Cotter was one of key officers of Closure Medical Corporation which was sold to JNJ in 2005.See Arch press release Arch Therapeutics Appoints Senior Management Team Members CAMBRIDGE, MA -- (Marketwired) -- 07/08/13

Johnson & Johnson and CLOSURE Medical Corporation Announce Acquisition Agreement
Acquisition to Strengthen Presence in Topical Adhesives and Surgical Sealants
NEW BRUNSWICK, N.J. and RALEIGH, N.C., March 4, 2005